MEDICINAL PRODUCTS CONTAINING HERBAL INGREDIENTS

Similar documents
DRAFT FOR CONSULTATION. Homeopathic Medicines: Guidance on advertising

Food supplements. Summary information on legislation relating to the sale of food supplements

NICOTINE INHALING PRODUCTS AGE OF SALE RESTRICTIONS & PROXY PURCHASING GUIDANCE FOR PHARMACIES KEY POINTS

A GUIDE TO WHAT IS A MEDICINAL PRODUCT

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

Proposals for the reform of the regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients

REPORT ON THE REGULATION OF HERBAL MEDICINES AND PRACTITIONERS

Advertising of medicines: Guidance for providers offering medicinal treatment services

«Human Consumption to a Significant Degree» Information and Guidance Document

REACH and Safety Data Sheets

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

Republic of Turkey. Date of acceptance: 9 November 2007 PART 1. Goal, scope, definitions and abbreviations. Goal and scope.

Regulatory requirements for Australia: Medicines, Cosmetics, Household Cleaning and Food Products RFA 2014

Draft guidance for registered pharmacies providing internet and distance sale, supply or service provision

2002 No. 618 CONSUMER PROTECTION. The Medical Devices Regulations 2002

The Regulation of Medical Devices in the UK

2 Human medicines: scope of regulation

Guidance on the In Vitro Diagnostic Medical Devices Directive 98/79/EC

APMI CODE OF PRACTICE ON ADVERTISING OF MEDICINAL PRODUCTS ISSUE 1

Guide to Definition of an Animal Remedy and the Classification Process

Glossary of terms used in our standards. June Upholding standards and public trust in pharmacy

This qualification has been reviewed. The last date to meet the requirements is 31 December 2017.

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products

Compilation of safety data sheets

Pharmacy Policy (General)

CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS

General Legal Requirements A guide for pharmacists in Northern Ireland 2010 Edition. Medicines for Veterinary Use

SMS SERVICE PROVISION

Draft guidance for registered pharmacies preparing unlicensed medicines

HOSPITAL PHARMACY PRACTICE IN THE UK AND THE RESPONSIBLE PHARMACIST REQUIREMENTS

DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004

Food Law and Due Diligence Defence

2015 No. 575 FINANCIAL SERVICES AND MARKETS. The Solvency 2 Regulations 2015

Waste Electrical and Electronic Equipment. Information Document

The Human Medicines Regulations 2012

2000 No MEDICINES. The Prescription Only Medicines (Human Use) Amendment Order 2000

Safeguarding public health The Regulation of Software as a Medical Device

INFORMATION FOR OBSERVERS. Project: Compliance Costs for REACH (Agenda Paper 3)

The Blue Guide ADVERTISING AND PROMOTION OF MEDICINES IN THE UK

Health (Tobacco, Nicotine etc. and Care) (Scotland) Bill [AS PASSED]

Guidance Notes on How to classify products as proprietary Chinese medicines. (Reference for the Trade)

REGULATION. on the advertising of medicinal products. SECTION I Definitions, scope and general provisions.

Decision on the CMA s review of the Credit Cards (Merchant Acquisition) Order 1990

An introduction to the regulation of apps and wearables as medical devices

Public Health (Wales) Bill

Standard conditions of the Electricity Distribution Licence

NEUROTONE THR 00904/0005 UKPAR

Regulatory Triage Assessment

JAN "CHAPTER BEHIND-THE-METER BATTERY RECYCLING. "Behind-the-meter renewable energy system" means a system

GUIDE TO IMPLEMENTING A REGULATORY FOOD SAFETY AUDITOR SYSTEM

FACT SHEET PREPARED BY THE MINISTRY OF JUSTICE ON THE DANGEROUS DRUGS (AMENDMENT) ACT 2015 OVERVIEW

NORTHERN TERRITORY ELECTRICITY RING-FENCING CODE

BANKING SUPERVISION UNIT

Foreign collective investment schemes

Guide for Custom-Made Dental Device Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES

AMERICAN PSYCHOLOGICAL ASSOCIATION

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

IMPORTANCE OF THE ENFORCEMENT OF THE LAW AND EU DIRECTIVES CONCERNING TRANSLATION OF PHARMACEUTICALS LEAFLETS

Serious Breaches. Ian Gravenor. Senior Clinical Project Manager Novo Nordisk Ltd

Chemicals Regulation: A comparison of US and European Approaches. James Searles

STANDARDS AND GUIDELINES TITLE: CIRCULATION DATE: March June 2013 REVISED: June 2013 APPROVAL DATE: July 29, 2013

PST-5 Issued: June 1984 Revised: August 2015 GENERAL INFORMATION

Professional Standards and Guidance for the Sale and Supply of Medicines

Standard conditions of the Electricity Distribution Licence

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?

House Study Bill Introduced

The Care Quality Commission makes the following provision for fees, in accordance with section 85(1) of the Health and Social Care Act

2015 No PUBLIC SECTOR INFORMATION. The Re-use of Public Sector Information Regulations 2015

Introduction to Guest House Classification Scheme. Registration & Classification

FINANCIAL ADVISERS ACT (CAP. 110)

Guidance for Advertisers of Homeopathic Services

Simple guide to the Companies Act 2006 (Amendment of Part 18) Regulations 2013 & 2015

The Care Quality Commission makes the following provision for fees, in accordance with section 85(1) of the Health and Social Care Act

Penalty Fares Rules. 55 VICTORIA STREET, LONDON SW1H 0EU TEL May 2002

Nutrition and health claims

Getting Your Claims Right

2015 No CONSUMER PROTECTION. The Alternative Dispute Resolution for Consumer Disputes (Amendment) Regulations 2015

QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

HSE: Frequently Asked Questions

CONSULTATION PAPER NO

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Retail Licence Exemptions for Solar Power Purchase Agreement Providers. Department of Finance Public Utilities July 2015

How To Know If A Mobile App Is A Medical Device

Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR

The Application and Inspection Process What to Expect

Changes to the Energy Performance of Buildings Framework. Policy update 5 Energy Performance Certificate compliance and enforcement

1999 No CONSUMER PROTECTION. The Unfair Terms in Consumer Contracts Regulations 1999

Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet

Urostemol Men capsules THR 02855/0240

FOR INFORMATION PURPOSES ONLY.

Code of Conduct for Marketing Retail Energy in Victoria

Terms of Business and Important Information We Must Disclose to You

FOOD LAW ENFORCEMENT IN SCOTLAND

THE INSTITUTE OF CHARTERED ACCOUNTANTS IN ENGLAND & WALES THE INSTITUTE OF CHARTERED ACCOUNTANTS OF SCOTLAND

Explanatory Memorandum to the Conservation of Habitats and Species (Amendment) Regulations 2012

As such, in light of the restricted timeframe given our response is only based on a limited consideration of all the factors.

European best practice regarding to the licensing in the energy sector

Distance selling: sale of consumer goods over the internet or telephone etc

Transcription:

MEDICINAL PRODUCTS CONTAINING HERBAL INGREDIENTS Introduction 1 The MHRA is responsible for the administration and enforcement of medicines legislation in the UK. The inclusion of herbal ingredients in a medicinal product does not take that product outside the definition of a medicinal product, but in some circumstances the product may be exempt from the licensing requirements of medicines legislation. The information in this note must be read in conjunction with Guidance Note 8 A guide to what is a medicinal product. 2 From the MHRA s viewpoint the first question to be addressed is whether or not the product is a medicinal product. If a product is not a medicinal product then the MHRA will not be involved in its regulation. Some herbs have well-known pharmacological effects and would usually only be found in products for a medicinal purpose. Such products would require marketing authorisations (formerly known as product licences) unless they come within the exemption mentioned below. The Legislation 3 All herbal medicines or remedies manufactured, sold or supplied in the UK are regulated by the Medicines For Human Use (Marketing Authorisations Etc.) Regulations 1994 (S.I.1994/3144) (which in part implements Directive 2001/83/EC) and the Medicines Act 1968 (the Act). 4 The definition of a medicinal product in Article 1.2 of Directive 2001/83/EC reads as follows: "Any substance or combination of substances presented for treating or preventing disease in human beings. Any substance or combination of substances which may be administered to human beings with a view to making a medical diagnosis or to restoring correcting or modifying physiological function in human beings is likewise considered a medicinal product". 5 If a product satisfies either or both of the above criteria, it may be classed as a medicinal product. In broad terms, when classifying a product, the Agency looks at the way it is presented and its function, that is, its effects (when administered) on human physiology. 6 Many herbs are used in medicine and a number have active substances that are capable of restoring, correcting or modifying 31 March 2005 1

physiological function or are presented as having such properties. Medicinal products with active herbal ingredients, or herbal ingredients that are presented as being active, may only be legally marketed in the UK with a marketing authorisation or, if they qualify, as exempt herbal remedies under section 12 of the Act. A product which comes within the terms of the Section 12 exemption is not regulated as a relevant medicinal product under S.I.1994/3144. Herbal Remedies 7 Section 132 of the Act defines a herbal remedy as: "... a medicinal product consisting of a substance produced by subjecting a plant or plants to drying, crushing or any other process, or of a mixture whose sole ingredients are two or more substances so produced, or of a mixture whose sole ingredients are one or more substances so produced and water or some other inert substance." 8 Section 12(1) allows a person to make, sell and supply a herbal remedy during the course of their business provided the remedy is manufactured or assembled on the premises and that it is sold or supplied as a consequence of a consultation between the person and their patient and in the patient's presence. 9 Section 12 (2) allows the manufacture, sale or supply of herbal remedies (other than by personal consultation) where:- the process to which the plant or plants are subjected consists only of drying, crushing or comminuting; the remedy is sold without any written recommendation as to its use, and the remedy is sold under a designation which only specifies the plant(s) and the process, and does not apply any other name to the remedy. Controls on the Retail Sale of Herbal Remedies Exempt from Licensing 10 There are further controls on the retail sale of medicinal products including herbal remedies in Sections 52, 53 and 56 of the Act. Sections 52 and 53 set conditions for the retail sale of medicinal products; Section 31 March 2005 2

56 provides exemptions from these conditions for those herbal remedies covered by the section 12 exemptions. Section 56 is however, limited by The Medicines (Retail Sale or Supply of Herbal Remedies) Order 1977 (S.I. 1977/2130). The Order is complex but in essence products containing the substances listed in Part 1 of the Schedule to the Order are excluded from the Section 56 exemption and may not be sold other than through a registered pharmacy and section 12(2) products listed in part II may not be sold other than through a registered pharmacy. 11 To sum up, if a product is a medicinal product it must have a marketing authorisation unless the product is also a herbal remedy within the definition in the Act. Then provided the conditions laid down in Section 12 of the Act are met, the product can be manufactured, sold and supplied without a licence. Sections 52 and 53 of the Act impose further conditions on the retail sale of the product unless the conditions in section 56 are satisfied and the product does not contain a substance listed in SI 1977/2130. The Traditional Herbal Medicines Directive 12 The Traditional Herbal Medicines Directive (Directive 2004/24/EC) was published on 30 April 2004 ("A" day). It introduces a registration scheme for traditional herbal medicines. The exemption from the requirement for a licence under Section 12(2) of the Act will be amended and, most, if not all, herbal remedies sold over the counter in the UK will have to be registered. The UK's associated legislation will come into force on 30 October 2005 ("B" day). There will be a transitional period of seven years for products which were legally on the market at "A" day. Products coming on to the market between "A" and "B" day must be registered by "B" day. All herbal remedies on the market must be registered by 30 April 2011 ("C" day). Further details may be obtained from the Agency's website 13 A product may be classified as medicinal because of the claims being made for it (as is currently the case). Products which include herbal ingredients for which a no is noted in the medicinal uses column in the list of herbal ingredients (see paras 18-21) may therefore be classified as medicinal products because of the way they are presented and as such would need to be registered. THE CLASSIFICATION OF HERBAL PRODUCTS 14 There are many herbs that are known to have medicinal uses and, at the same time, have known uses as either foods or cosmetics. The MHRA obtains its information from various sources, but mostly from 31 March 2005 3

respected textbooks and published data. Occasionally the MHRA has to consider the status of a herb that does have uses other than medicinal ones and in such cases, will make a judgement as to which is the dominant function and pay particular regard to the purpose of the herb s inclusion in a particular product. 15 Where the available data suggests that a herb has food uses which are limited to the local indigenous population of its country of origin, then it is unlikely to be regarded as the dominant function - especially if its origins lie in a different continent, particularly where its consumption is for a purpose other than nutrition. 16 When the MHRA considers the uses and property of a particular herb, we consider the known/reported uses of the herb, whether those uses apply to the whole plant or a particular part of the plant (leaves, fruit, root etc.) and how this information relates to the product in question. The MHRA also considers the amount of each ingredient when coming to a view on the status of a product. Nothing in this guidance affects a company s right to a review by the Independent Review Panel where a provisional determination is issued. Please see Guidance Note 8 A guide to what is a medicinal product for information on how the MHRA assesses the claims made for a product. 17 UK medicines legislation does not provide a definitive list of substances whose inclusion automatically makes a product a medicinal product. The decision as to whether or not a product is a medicinal product is made on a case by case basis taking into account the factors set out in paragraphs 11-23 of Guidance Note 8. Herbal Aide-Memoire 18 To assist companies in determining the likely status of their product the MHRA has compiled a list of herbal ingredients. The list gives the botanical and other names of various plants together with the known uses of those plants. 19 The list is not exhaustive and the following points should always be considered - The list is for information only, the status of a product under medicines legislation is determined on a individual basis taking into account all the factors detailed in Guidance Note 8. Products which contain an ingredient for which a no is noted in the medicinal uses column may nonetheless be classified as medicinal depending on the product s presentation 31 March 2005 4

The list has no legal status If a product is not a medicinal product advice should be sought from the relevant regulatory body on the legality of that product. The fact that a product is not a medicinal product does not necessarily mean that it is safe, acceptable or legal under other legislation. For example a herbal product may be a food, cosmetic or a consumer product and specific legislation will apply. Manufacturers should therefore consult the appropriate regulatory bodies, including the Food Standards Agency (FSA) (for foods and food supplements), the Department of Trade and Industry (for cosmetics or consumer products). Additional information may be obtained from the Trading Standards Service of the relevant Local Authority. Although food use may be recorded or reported for a herbal ingredient it is for an individual to check with the FSA that a herb or product is safe for human consumption. The Food Safety Act (1990) states that all food sold in the UK should not be injurious to health. The MHRA accepts no responsibility on this point. In addition, we have been advised by the FSA that herbal ingredients which do not have a history of significant consumption within the EU prior to May 1997 may be subject to the controls of Novel Food Regulation (EC) 258/97. Advice on this point should be sought from the Food Standards Agency either in writing or by e- mailing herbals@foodstandards.gsi.gov.uk. 20 The list gives the following information: Botanical name Common name Any recorded medicinal uses Any recorded food uses. Recorded use in aromatherapy Recorded use in cosmetic products General comments The part(s) of the plant used medicinally 31 March 2005 5